bupropion glp 1 GLP-1s linked to lower rates of anxiety and depression than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone Pharmacotherapy for Obesity: Recent Updates

Differentiated positioning: Launch a dual delivery system to build technical barriers

Its a rare optic nerve injury sometimes described as a stroke of the eye, which can cause sudden, irreversible vision loss

Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt J, Geiger JT, Van der Spek RA, Pliner HA, Shankaracharya SBN, Landers JE (2018) Genome-wide analyses identify KIF5A as a novel ALS gene

Consequently, improving amylin-based medicines focuses on enabling longer action, resulting in weekly use, possibly even oral use and, most importantly, combining the functions of more than one hormone known for being involved in glucose control and the promotion of satiety

2017;25(5):1075e10905